Market cap
₹98 Cr
Revenue (TTM)
₹26 Cr
P/E Ratio
--
P/B Ratio
8.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -5.41 | 17.55 | 14.56 | 22.49 | 5.77 |
| EBIT | 90.93 | -114.47 | -123.61 | -9.60 | -166.45 |
| Net Profit | 94.48 | -108.09 | -117.74 | 4.06 | -164.66 |
| EPS | 94.49 | -108.08 | -117.74 | 4.06 | -164.13 |
| Book Value | -- | -- | 20.44 | -1.52 | 23.75 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-25 | Mar-24 |
| EBIT-Margin
| -3.79 | 5.24 | -2.29 | 9.23 | -20.64 |
| Net Margin
| -3.65 | 4.13 | -1.72 | 9.03 | -19.61 |
| Return on equity
| -1.83 | 11.91 | -3.41 | 18.13 | -26.34 |
| Return on Capital
| 1.19 | 13.34 | -- | 19.27 | -20.54 |
| Return on Assets
| -1.44 | 7.22 | -2.52 | 12.57 | -18.17 |
| Debt to Equity (x)
| -- | -- | 0.11 | 0.10 | 0.11 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
19.64
|
-18.49
|
2.40
|
41.63
|
|
Peer Median
|
--
|
-2.22
|
4.55
|
13.69
|
--
|
ROE
-3.41
Lower than Peers by 3.74
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-3.41
|
18.54
|
-23.34
|
-0.69
|
42.26
|
|
Peer Median
|
0.33
|
-3.56
|
2.06
|
12.85
|
--
|
ROA
-2.52
Lower than Peers by 2.13
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-2.52
|
12.86
|
-16.67
|
-0.50
|
29.82
|
|
Peer Median
|
-0.39
|
-2.73
|
1.49
|
9.99
|
--
|
EBIT Margin
-2.29
Lower than Peers by 6.23
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-2.29
|
9.23
|
-20.64
|
0.05
|
23.95
|
|
Peer Median
|
3.94
|
8.20
|
8.08
|
9.36
|
--
|
Net Margin
-1.72
Lower than Peers by 3.10
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-1.72
|
9.26
|
-19.61
|
-0.60
|
22.64
|
|
Peer Median
|
1.38
|
-0.01
|
3.55
|
11.92
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
16.21
|
-8.58
|
10.35
|
31.19
|
|
Peer Median
|
--
|
0.00
|
0.00
|
0.00
|
--
|
Revenue Growth
14.56
Higher than Peers by 7.76
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
14.56
|
66.60
|
-8.66
|
-26.02
|
28.52
|
|
Peer Median
|
6.80
|
9.33
|
2.48
|
19.31
|
--
|
EBIT Growth
-123.61
Lower than Peers by 112.13
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-123.61
|
174.52
|
-35,963.16
|
-99.84
|
126.26
|
|
Peer Median
|
-11.48
|
92.72
|
40.29
|
-6.52
|
--
|
Net Profit Growth
-117.74
Lower than Peers by 74.29
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-117.74
|
177.56
|
-2,912.63
|
-101.99
|
222.91
|
|
Peer Median
|
-43.46
|
71.34
|
17.91
|
172.05
|
--
|
EPS Growth
-117.74
Lower than Peers by 91.02
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-117.74
|
177.56
|
-2,911.72
|
-101.99
|
222.91
|
|
Peer Median
|
-26.72
|
71.34
|
--
|
283.33
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
20.44
|
-20.45
|
-0.31
|
53.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.11
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
0.11
|
0.10
|
0.11
|
0.08
|
0.07
|
|
Peer Median
|
--
|
0.14
|
0.11
|
0.14
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.43
Higher than Peers by 0.00
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
1.43
|
2.26
|
2.10
|
3.70
|
3.99
|
|
Peer Median
|
1.43
|
1.91
|
2.45
|
2.04
|
--
|
Quick Ratio
1.22
Higher than Peers by 0.05
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
1.22
|
2.05
|
1.89
|
3.44
|
3.77
|
|
Peer Median
|
1.17
|
1.42
|
1.81
|
1.87
|
--
|
Interest Coverage
-0.17
Lower than Peers by 7.14
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-0.17
|
6.97
|
-6.27
|
0.79
|
12.97
|
|
Peer Median
|
6.97
|
-1.38
|
4.03
|
16.53
|
--
|
Operating Efficiency
Debtors to sales
6.69
Lower than Peers by 7.62
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
6.69
|
10.69
|
16.98
|
16.17
|
22.98
|
|
Peer Median
|
14.32
|
19.78
|
16.98
|
21.48
|
--
|
Asset Turnover
1.44
Higher than Peers by 0.71
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
1.44
|
1.37
|
0.82
|
0.82
|
1.31
|
|
Peer Median
|
0.73
|
1.11
|
0.78
|
0.90
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
38.11
|
63.31
|
86.22
|
57.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
7.95
|
11.69
|
10.14
|
7.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
72.32
|
74.56
|
69.77
|
74.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
-26.26
|
0.44
|
26.59
|
-9.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-216.27
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-216.27
|
42.33
|
--
|
--
|
14.96
|
|
Peer Median
|
--
|
162.58
|
47.34
|
26.10
|
--
|
Price / Book Value
8.05
Higher than Peers by 5.64
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
8.05
|
7.18
|
3.15
|
2.25
|
5.22
|
|
Peer Median
|
2.41
|
2.70
|
1.79
|
3.17
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
64.55
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
64.55
|
22.18
|
-41.27
|
14.25
|
10.19
|
|
Peer Median
|
--
|
-19.96
|
20.34
|
9.39
|
--
|
Market Cap
98
Higher than Peers by 60
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
98
|
88
|
32
|
29
|
67
|
|
Peer Median
|
38
|
55
|
32
|
45
|
--
|